Health Catalyst, Inc. (HCAT) stock
HCATNasdaqServices-Computer Programming, Data Processing, Etc.Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 5/3075% below fair value
$1.37−0.01 (-0.72%)
Close on Nov 17, 2026Market cap $103.10MP/E –Yield –
Health Catalyst price to sales ratio
The price-to-sales ratio is market cap divided by revenue over the trailing twelve months.
Health Catalyst's price to sales ratio was 0.4× on Nov 11, 2026, against 0.7× a year earlier. Over the last 5 years it ranged from 0.3× to 8.9×, with a median of 1.5×.
Price to Sales Ratio at the end of each year
| Period | Period end | Value | Change (pts) |
|---|---|---|---|
| 2026 | Nov 11, 2026 | 0.4× | −0.2 |
| 2025 | Dec 31, 2025 | 0.5× | −0.9 |
| 2024 | Dec 31, 2024 | 1.4× | −0.4 |
| 2023 | Dec 29, 2023 | 1.8× | −0.3 |
| 2022 | Dec 30, 2022 | 2.1× | −6.8 |
| 2021 | Dec 31, 2021 | 8.9× | −1.4 |
| 2020 | Dec 31, 2020 | 10.3× | +1.7 |
| 2019 | Dec 31, 2019 | 8.6× | – |
See a number that looks wrong?